Phase III trials reach primary endpoint! Eli Lilly (LLY.US) plans to expand Omvoh indications for treatment of pediatric ulcerative colitis
智通财经2026/10/20 07:07Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhihui Finance APP, Eli Lilly (LLY.US) announced on Monday that, after achieving success in a late-stage trial of its Omvoh injection for children with ulcerative colitis, the company plans to seek an expansion of indications for this intestinal disease therapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Stocks Fluctuation: Klaviyo Surges on October 20 Due to Discounted Valuation and B2C CRM
Bitget异动解读•2026/10/20 13:41
[US Stock Market Movement] Hertz surges on October 20: Oro receives $80 million investment
Bitget异动解读•2026/10/20 13:41
